Nucala
NDC 0173-0904, mepolizumab, injection, solution, from GlaxoSmithKline LLC.
- Product NDC
- 0173-0904
- Status
- Listed
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761122
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0904 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEPOLIZUMAB40 mg/.4mL
Pharmacologic classes
Interleukin-5 Antagonist [EPC]; Interleukin-5 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0173-0904-42 | 00173090442 | 1 SYRINGE in 1 CARTON (0173-0904-42) / .4 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fefb887c-e4ac-431e-8893-e9d1a5a63fea
Use it
Look up 0173-0904 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0904 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0173-0904. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.